These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31315424)

  • 1. Loratadine for Paclitaxel-Induced Myalgias and Arthralgias.
    Smith C; Hendrickson AW; Grudem M; Klampe C; Deering E; Jatoi A
    Am J Hosp Palliat Care; 2020 Mar; 37(3):235-238. PubMed ID: 31315424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myalgias and arthralgias associated with paclitaxel.
    Garrison JA; McCune JS; Livingston RB; Linden HM; Gralow JR; Ellis GK; West HL
    Oncology (Williston Park); 2003 Feb; 17(2):271-7; discussion 281-2, 286-8. PubMed ID: 12632867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias.
    Jacobson SD; Loprinzi CL; Sloan JA; Wilke JL; Novotny PJ; Okuno SH; Jatoi A; Moynihan TJ
    J Support Oncol; 2003; 1(4):274-8. PubMed ID: 15334869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Gynecol Oncol; 1999 Jan; 72(1):100-1. PubMed ID: 9889038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine treatment of paclitaxel-induced myalgias and arthralgias.
    Savarese D; Boucher J; Corey B
    J Clin Oncol; 1998 Dec; 16(12):3918-9. PubMed ID: 9850043
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of paclitaxel-associated arthralgias and myalgias.
    Markman M
    J Support Oncol; 2003; 1(4):233-4. PubMed ID: 15334864
    [No Abstract]   [Full Text] [Related]  

  • 7. 3-hour infusion of single-agent paclitaxel for recurrent ovarian cancer.
    Ishikawa H; Nakanishi T; Nawa A; Suzuki Y; Kuzuya K
    Int J Clin Oncol; 2001 Jun; 6(3):128-31. PubMed ID: 11706781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias.
    Nguyen VH; Lawrence HJ
    J Clin Oncol; 2004 May; 22(9):1767-9. PubMed ID: 15118009
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary experience with salvage weekly paclitaxel in women with advanced recurrent ovarian carcinoma.
    Dunder I; Berker B; Atabekoglu C; Bilgin T
    Eur J Gynaecol Oncol; 2005; 26(1):79-82. PubMed ID: 15755007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between myalgias/arthralgias occurring in patients receiving quinupristin/dalfopristin and biliary dysfunction.
    Raad I; Hachem R; Hanna H
    J Antimicrob Chemother; 2004 Jun; 53(6):1105-8. PubMed ID: 15128724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel efficacy and tolerability in second-line treatment of refractory and relapsed ovarian cancer patients.
    Oliverio G; Canuti D; Tononi A; Scarpellini M; Panzini I; Galli I; Ravaioli A
    J Chemother; 1999 Aug; 11(4):301-5. PubMed ID: 10465133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy.
    Carver PL; Whang E; VandenBussche HL; Kauffman CA; Malani PN
    Pharmacotherapy; 2003 Feb; 23(2):159-64. PubMed ID: 12587804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemia.
    Colburn DE; Thomas DA; Giles FJ
    Invest New Drugs; 2003 Feb; 21(1):109-11. PubMed ID: 12795536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of L-Glutamine and Shakuyaku-Kanzo-to for paclitaxel-induced myalgia/arthralgia].
    Hasegawa K; Mizutani Y; Kuramoto H; Nagao S; Masuyama H; Hongo A; Kodama J; Yoshinouchi M; Hiramatsu Y; Kudo T; Okuda H
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):569-74. PubMed ID: 11977541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-pelvic metastasis of endometrioid carcinoma; resistance to chemo-radiation therapy--response to paclitaxel treatment. Case report.
    Hornreich G; Hiller N; Neuman M; McDaniel C; Winograd B; Lavie O; Beller U
    Eur J Gynaecol Oncol; 1995; 16(4):263-7. PubMed ID: 7556281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel (Taxol)--a guide to administration.
    Preston NJ
    Eur J Cancer Care (Engl); 1996 Sep; 5(3):147-52. PubMed ID: 9117048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone-induced arthralgia and myalgia in the treatment of sinusitis.
    O-Lee T; Stewart CE; Seery L; Church CA
    Am J Rhinol; 2005; 19(4):395-9. PubMed ID: 16171175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.
    Cantù MG; Buda A; Parma G; Rossi R; Floriani I; Bonazzi C; Dell'Anna T; Torri V; Colombo N
    J Clin Oncol; 2002 Mar; 20(5):1232-7. PubMed ID: 11870165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.